|Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells.|
|PMID: 15563545 Owner: NLM Status: MEDLINE|
|Fas-mediated apoptosis has been proposed to play an important role in the pathogenesis of Hashimoto's thyroiditis. Normal thyroid cells are resistant to Fas-mediated apoptosis in vitro but can be sensitized by the unique combination of interferon-gamma and IL-1beta cytokines. We sought to examine the mechanism of this sensitization and apoptosis signaling in primary human thyroid cells. Without the addition of cytokines, agonist anti-Fas antibody treatment of the thyroid cells resulted in the cleavage of proximal caspases, but this did not lead to the activation of caspase 7 and caspase 3. Apoptosis associated with the cleavage of caspases 7, 3, and Bid, and the activation of mitochondria in response to anti-Fas antibody occurred only after cytokine pretreatment. Cell surface expression of Fas, the cytoplasmic concentrations of procaspases 7, 8, and 10, and the proapoptotic molecule Bid were markedly enhanced by the presence of the cytokines. In contrast, P44/p42 MAPK (Erk) appeared to provide protection from Fas-mediated apoptosis because an MAPK kinase inhibitor (U0126) sensitized thyroid cells to anti-Fas antibody. In conclusion, Fas signaling is blocked in normal thyroid cells at a point after the activation of proximal caspases. Interferon-gamma/IL-1beta pretreatment sensitizes human thyroid cells to Fas-mediated apoptosis in a complex manner that overcomes this blockade through increased expression of cell surface Fas receptor, increases in proapoptotic molecules that result in mitochondrial activation, and late caspase cleavage. This process involves Bcl-2 family proteins and appears to be compatible with type II apoptosis regulation.|
|Emese Mezosi; Su He Wang; Saho Utsugi; Laszlo Bajnok; James D Bretz; Paul G Gauger; Norman W Thompson; James R Baker|
Related Documents :
|18561025 - Blockade of the fas/fas ligand interaction suppresses hepatocyte apoptosis in ischemia-...
15104235 - Acacetin inhibits the proliferation of hep g2 by blocking cell cycle progression and in...
9431985 - The proteolytic cleavage of protein kinase c isotypes, which generates kinase and regul...
16364925 - Overexpression of thymosin beta-4 renders sw480 colon carcinoma cells more resistant to...
9801925 - The neutrophil: one of the cellular targets of interleukin-10.
11997075 - Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricl...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. Date: 2004-11-24|
|Title: Molecular endocrinology (Baltimore, Md.) Volume: 19 ISSN: 0888-8809 ISO Abbreviation: Mol. Endocrinol. Publication Date: 2005 Mar|
|Created Date: 2005-02-24 Completed Date: 2005-06-28 Revised Date: 2009-11-19|
Medline Journal Info:
|Nlm Unique ID: 8801431 Medline TA: Mol Endocrinol Country: United States|
|Languages: eng Pagination: 804-11 Citation Subset: IM|
|Department of Medicine, University of Michigan Medical Center, 9220 Medical Sciences Research Building III, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109-0648, USA.|
|APA/MLA Format Download EndNote Download BibTex|
BH3 Interacting Domain Death Agonist Protein
Butadienes / pharmacology
Carrier Proteins / metabolism
Caspases / metabolism
Cell Membrane / metabolism
Cytokines / metabolism
Enzyme Inhibitors / pharmacology
Epithelial Cells / cytology*
Interferon-gamma / metabolism
Interleukin-1 / metabolism
Mitochondria / metabolism
Mitogen-Activated Protein Kinase 1 / metabolism
Mitogen-Activated Protein Kinase 3 / metabolism
Nitriles / pharmacology
Proto-Oncogene Proteins c-bcl-2 / metabolism
Reverse Transcriptase Polymerase Chain Reaction
Ribonucleases / metabolism
Thyroid Gland / cytology, metabolism*, pathology*
|P60DK20572/DK/NIDDK NIH HHS; R01 A137141//PHS HHS|
|0/Antigens, CD95; 0/BH3 Interacting Domain Death Agonist Protein; 0/BID protein, human; 0/Butadienes; 0/Carrier Proteins; 0/Cytokines; 0/Enzyme Inhibitors; 0/Interleukin-1; 0/Nitriles; 0/Proto-Oncogene Proteins c-bcl-2; 0/U 0126; 82115-62-6/Interferon-gamma; EC 184.108.40.206/Mitogen-Activated Protein Kinase 1; EC 220.127.116.11/Mitogen-Activated Protein Kinase 3; EC 3.1.-/Ribonucleases; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/CASP7 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 7; EC 3.4.22.-/Caspases|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive...
Next Document: Membrane-proximal region of the carboxyl terminus of the gonadotropin-releasing hormone receptor (Gn...